These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 2949799
1. Central effects of vasopressin and 1-desamino-8-D-arginine vasopressin (DDAVP) on interleukin-1 fever in the rat. Naylor AM, Gubitz GJ, Dinarello CA, Veale WL. Brain Res; 1987 Jan 13; 401(1):173-7. PubMed ID: 2949799 [Abstract] [Full Text] [Related]
2. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats. Federico P, Veale WL, Pittman QJ. Am J Physiol; 1992 May 13; 262(5 Pt 2):R901-8. PubMed ID: 1534208 [Abstract] [Full Text] [Related]
3. Evidence supporting a role for endogenous vasopressin in fever suppression in the rat. Cooper KE, Naylor AM, Veale WL. J Physiol; 1987 Jun 13; 387():163-72. PubMed ID: 3498828 [Abstract] [Full Text] [Related]
4. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system. Croiset G, De Wied D. Brain Res; 1997 Jun 06; 759(1):18-23. PubMed ID: 9219858 [Abstract] [Full Text] [Related]
5. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors. Manning M, Misicka A, Olma A, Klis WA, Bankowski K, Nawrocka E, Kruszynski M, Kolodziejczyk A, Cheng LL, Seto J. J Med Chem; 1987 Dec 06; 30(12):2245-52. PubMed ID: 2960812 [Abstract] [Full Text] [Related]
6. Prevention of arginine-vasopressin-induced motor disturbances by a potent vasopressor antagonist. Burnard DM, Veale WL, Pittman QJ. Brain Res; 1986 Jan 01; 362(1):40-6. PubMed ID: 2867814 [Abstract] [Full Text] [Related]
7. Arginine vasopressin-induced sensitization in brain: facilitated inositol phosphate production without changes in receptor number. Poulin P, Pittman QJ. J Neuroendocrinol; 1993 Feb 01; 5(1):23-31. PubMed ID: 8485541 [Abstract] [Full Text] [Related]
8. Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin. Martínez MC, Vila JM, Aldasoro M, Medina P, Flor B, Lluch S. Br J Pharmacol; 1994 Oct 01; 113(2):419-24. PubMed ID: 7834191 [Abstract] [Full Text] [Related]
9. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules. Champigneulle A, Siga E, Vassent G, Imbert-Teboul M. Am J Physiol; 1993 Jul 01; 265(1 Pt 2):F35-45. PubMed ID: 8342613 [Abstract] [Full Text] [Related]
10. Central vasopressin V1-blockade prevents salicylate but not acetaminophen antipyresis. Wilkinson MF, Kasting NW. J Appl Physiol (1985); 1990 May 01; 68(5):1793-8. PubMed ID: 2361881 [Abstract] [Full Text] [Related]
11. Indomethacin-induced antipyresis in the rat: role of vasopressin receptors. Fyda DM, Cooper KE, Veale WL. Brain Res; 1989 Aug 14; 494(2):307-14. PubMed ID: 2528390 [Abstract] [Full Text] [Related]
15. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors. Cheng SW, North WG. Brain Res; 1989 Feb 06; 479(1):35-9. PubMed ID: 2522339 [Abstract] [Full Text] [Related]
18. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors. Feng JJ, Arendshorst WJ. Am J Physiol; 1996 Aug 06; 271(2 Pt 2):F304-13. PubMed ID: 8770161 [Abstract] [Full Text] [Related]
19. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor. Saito M, Tahara A, Sugimoto T. Biochem Pharmacol; 1997 Jun 01; 53(11):1711-7. PubMed ID: 9264324 [Abstract] [Full Text] [Related]
20. Central vasopressin blockade enhances its peripheral release in response to peripheral osmotic stimulation in conscious rats. Liu HW, Wang YX, Crofton JT, Funyu T, Share L. Brain Res; 1996 May 06; 719(1-2):14-22. PubMed ID: 8782858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]